Offstream
news

---

Changes

1. Johnson & Johnson requests emergency approval for their vaccine from the Food and Drug Administration.
   2021-02-06 09:05:08 (First version)
2. Johnson & Johnson requests emergency approval for its vaccine from the Food and Drug Administration.
   (Current version)

---

Related

The U.S. FDA grants approval for the Pfizer–BioNTech COVID-19 vaccine for people aged between 12 and 17.
2022-07-8

The U.S. FDA issues a full approval for the Moderna COVID-19 vaccine for use in adults.
2022-01-31

The Food and Drug Administration authorizes the use of the Pfizer–BioNTech COVID-19 vaccine as a booster dose for children between the ages of 12 and 15 years, becoming the world's first vaccine to be authorized as a booster shot for this age group.
2022-01-3

The FDA announces its approval for measures allowing the Pfizer–BioNTech COVID-19 vaccine to be stored at regular refrigerator temperatures for up to 30 days before administration. Previously, the agency had only allowed such storage for five days.
2021-05-20

The Food and Drug Administration approves the single-dose Johnson & Johnson vaccine for emergency use in the United States.
2021-02-27

Johnson & Johnson's single-shot COVID-19 vaccine candidate meets the standards for emergency use authorization, according to analysis from a committee within the FDA, though formal authorization will not be determined until February 26. The vaccine is 66% effective in combating the virus and can be stored in normal refrigerators.
2021-02-24

South Africa begins its vaccination campaign against COVID-19 using a vaccine from Johnson & Johnson, which has not yet been authorized worldwide. President Cyril Ramaphosa, government officials, and health workers are among the first to receive the vaccine.
2021-02-17

The U.S. Food and Drug Administration authorizes the Moderna COVID-19 vaccine for emergency use.
2020-12-18

The Food and Drug Administration approves remdesivir to treat COVID-19 in hospitalized patients. The drug, manufactured by the pharmaceutical company Gilead under the brand name Veklury, is the first fully approved COVID-19 treatment in the United States.
2020-10-22

The Food and Drug Administration issues an emergency use authorization for COVID-19 pool testing.
2020-07-18